Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126345402 | 12634540 | 2 | F | 2013 | 20160804 | 20160808 | 20160809 | EXP | PHHY2016BR108392 | NOVARTIS | 0.00 | M | Y | 42.00000 | KG | 20160809 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126345402 | 12634540 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 320 MG, Q12H | 1519837 | 21283 | 320 | MG | TABLET | Q12H | |||||
| 126345402 | 12634540 | 2 | SS | TRAVATAN | TRAVOPROST | 1 | Oral | UNK UNK, QD (ONCE DAILY) | 24246575S | 0 | EYE DROPS | QD | |||||||
| 126345402 | 12634540 | 3 | SS | TRAVATAN | TRAVOPROST | 1 | 0 | EYE DROPS | |||||||||||
| 126345402 | 12634540 | 4 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 2 DF, QD (EVERY 12 HOURS) | U | GC 5056 | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126345402 | 12634540 | 1 | Hypertension |
| 126345402 | 12634540 | 2 | Glaucoma |
| 126345402 | 12634540 | 3 | Ocular hypertension |
| 126345402 | 12634540 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126345402 | 12634540 | HO |
| 126345402 | 12634540 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126345402 | 12634540 | Arterial occlusive disease | |
| 126345402 | 12634540 | Blood pressure increased | |
| 126345402 | 12634540 | Cerebrovascular accident | |
| 126345402 | 12634540 | Complication associated with device | |
| 126345402 | 12634540 | Feeling abnormal | |
| 126345402 | 12634540 | Gait disturbance | |
| 126345402 | 12634540 | Heart rate decreased | |
| 126345402 | 12634540 | Hemiparesis | |
| 126345402 | 12634540 | Myocardial infarction | |
| 126345402 | 12634540 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |